세계 척추 임플란트 시장 규모는 2023년 130억 1,000만 달러, 2030년까지 178억 4,000만 달러에 달할 것으로 예상되며, 2024-2030년의 예측 기간 동안 연평균 5.40%의 성장률을 나타낼 전망입니다. 척추 임플란트에 대한 수요 증가는 전 세계 노인층에서 척추관 협착증, 추간판 탈출증, 추간판 퇴행성 질환 등 다양한 척추 질환의 유병률 증가가 주요 원인으로 작용하고 있습니다. 또한, 뼈 이식 제품의 기술 발전에 대한 관심 전환, 척추 질환 및 적절한 관리에 대한 환자의 인식 증가, 최소 침습 수술에 대한 선호도 증가 등이 척추 임플란트 시장을 촉진하는 요인으로 작용하고 있습니다.
척추 임플란트 시장 역학
척추 임플란트 수요는 교통사고, 낙상, 노화로 인한 척추 관련 변형으로 고통받는 사람들이 전 세계적으로 증가함에 따라 전례 없는 속도로 증가하고 있으며, World Population Ageing 2020 Highlights의 통계에 따르면, 전 세계 65세 이상 인구의 비율은 2020년 9.3%에서 2050년까지 약 16.0%로 증가할 것으로 예측됩니다. 고령화가 진행됨에 따라 추간판 퇴행성 질환이나 척추관 협착증과 같은 척추 변형이 발생하기 쉽다. 예를 들어, 2020년 NCBI에서 발표된 Wu L.과 Cruz R.의 연구 'Lumbar Spinal Stenosis'에 따르면, 후천성 요추관 협착증 유병률은 60-69세 인구에서 19.4%로 나타났습니다.
또한, 비정부기구인 Spinal Cord Injuries Australia의 2022년 통계에 따르면, 호주 인구 중 약 15,000명이 척수 손상을 안고 살아가고 있으며, 교통사고가 전체 사례의 46%를 차지하는 반면, 낙상은 전체 외상성 SCI의 약 36%를 차지한다고 합니다. 36%를 차지합니다.
또한, 표준 관혈적 수술에 비해 절개창이 작고, 근육 손상이 적으며, 출혈량과 수술 후 재원일수가 감소하는 등 장점이 있어 저침습적 척추 수술에 대한 수요가 급증하고 있는 점도 예측 기간 동안 세계 척추 임플란트 장치에 기여할 것으로 예상됩니다.
이러한 모든 요인들이 세계 척추 임플란트 시장을 강화할 가능성이 높습니다.
그러나 임플란트에 대한 엄격한 규제와 수술뿐만 아니라 고가의 장치와 같은 특정 요인이 척추 임플란트 시장의 성장을 저해할 가능성이 높습니다.
척추 임플란트 시장 부문별 분석
척추 임플란트 제품 부문에서는 척추 고정 장치가 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 이는 시장에서 다양한 유형의 척추 고정 장치를 사용할 수 있기 때문입니다. 2018년 발표된 NCBI의 연구 "Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide Volume"에 따르면, 전 세계적으로 요추 퇴행성 질환의 유병률이 증가하고 있는 것도 이 부문 시장 활성화에 기여할 것으로 예상됩니다. Global Incidence and Worldwide Volume'에 따르면, 매년 전 세계적으로 총 2억 6,600만 명(3.63%)이 요추 퇴행성 척추 질환(DSD)과 요통(LBP)을 앓고 있는 것으로 나타났습니다.
또한, 최근 몇 년동안 첨단 기술이 적용된 척추 고정 장치 포트폴리오의 제품 승인도 이 부문 시장에 박차를 가할 것으로 예상됩니다. 예를 들어, 2020년 8월 이노바시스는 아나노 표면을 가진 다공성 척추간 장치로 최초로 Special 510(k) 승인을 획득했습니다. 새로 승인된 이노바시스의 마이크로 다공성 3D 프린팅 티타늄 소재의 장치에는 전방 요추 추간판 고정술(ALIF)을 위한 독립형 IBF 장치인 AxTiHA(TM) 시스템이 포함됩니다.
북미가 전체 척추 임플란트 시장을 독점할 것으로 예상됩니다.
예측 기간 동안 북미가 전체 척추 임플란트 시장을 독점할 것으로 예상됩니다. 이러한 우위는 이 지역의 척추 수술에 대한 잘 확립된 상환 시나리오에 기인합니다. 또한, 적절한 첨단 의료 시설의 존재와 이 지역의 요통 유병률 증가도 이 지역 시장 성장에 기여하고 있습니다.
이 보고서는 세계 척추 임플란트 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등의 정보를 전해드립니다.
Spinal Implants Market By Product Type (Spinal Fusion & Fixation Devices [Thoracolumbar Devices, Cervical Fixation Devices, and Interbody Fusion Devices], Motion Preservation/Non-Fusion Devices [Artificial Disc Replacement, Dynamic Stabilization Devices, Annulus Repair Devices, and Others], Vertebral Compression Fracture Treatment Devices/Spine Augmentation Devices [Vertebroplaty Devices, Balloon Kyphoplasty Devices], Spine Biologics [Demineralized Bone Matrix, Bone Morphogenetic Proteins, Allografts, and Others]), By End-User (Hospitals, Orthopedic Clinics, and Others), By Geography is anticipated to expand at a modest CAGR forecast till 2030 due to rising prevalence of spinal disorders and technological advancement in the field of spinal implants.
The global Spinal Implants Market was valued at USD 13.01 billion in 2023, growing at a CAGR of 5.40% during the forecast period from 2024 to 2030 to reach USD 17.84 billion by 2030. The rise in demand for Spinal Implants is predominantly attributed due to the increasing prevalence of various spinal disorders which include spinal stenosis, disc herniation, and degenerative disc diseases, among others in the older population across the globe. Moreover, shifting focus towards technological advancement in bone graft products, rising awareness among the patient population regarding spinal disorder and their proper management, and rising preferences for minimally invasive surgeries are the factors driving the spinal implants market.
Spinal Implants Market Dynamics:
The demand for the spinal implants are growing at an unprecedented rate because of the rising population suffering with spinal related deformities caused due to road traffic crashes, falls, or increasing age across the globe. The world population is aging, according to the statistics of World Population Ageing 2020 Highlights, globally, the share of the population aged 65 years or over is expected to increase from 9.3 % in 2020 to around 16.0 % in 2050. Rising aging population are more susceptible to develop spinal deformities such as degenerative disc disorders, spinal stenosis, and others. For instance, according to a study: Lumbar Spinal Stenosis by Wu L. and Cruz R. published in NCBI in the year 2020, the prevalence of acquired lumbar spinal stenosis was 19.4% for the population aged between 60 and 69 years.
Moreover, according to the 2022 statistics of the Spinal Cord Injuries Australia, a non-government organization, approximately 15000 of the Australian population live with a spinal cord injury and traffic crashes contribute to 46% of all the cases whereas falls contribute to around 36% of all the traumatic SCI cases.
In addition, burgeoning demand for the minimally invasive spinal surgical procedures owing to the advantages such as smaller incisions, less muscle damage, decreased blood loss and length of hospital stay following surgery in comparison to standard open approach will also contribute to the global spinal implant devices during the forecasted period.
Thus, all the aforementioned factors are likely to bolster the global spinal implants market.
However, certain factors such as stringent regulatory for the implants and high cost of the devices as well as surgery are likely to hinder the spinal implants market growth.
Spinal Implants Market Segment Analysis:
Spinal Implants Market By Product Type (Spinal Fusion & Fixation Devices [Thoracolumbar Devices, Cervical Fixation Devices, and Interbody Fusion Devices], Motion Preservation/Non-Fusion Devices [Artificial Disc Replacement, Dynamic Stabilization Devices, Annulus Repair Devices, and Others], Vertebral Compression Fracture Treatment Devices/Spine Augmentation Devices [Vertebroplaty Devices, Balloon Kyphoplasty Devices], Spine Biologics [Demineralized Bone Matrix, Bone Morphogenetic Proteins, Allografts, and Others]), By End-User (Hospitals, Orthopedic Clinics, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Spinal Implants product segment, spinal fusion and fixation devices are expected to hold a largest market share during the forecast period. This is due to the availability of a wide range of spinal fusion and fixation devices in the market. Also, increasing lumbar spine degeneration prevalence across the globe is expected to fuel the segmental market. According to a NCBI study: Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide Volume by Ravindra M.V. et al., published in the year 2018, a total of 266 million individuals (3.63%) worldwide were found to have Lumbar degenerative spine disease (DSD) and low back pain (LBP) annually.
Furthermore, recent product approvals in spinal fusion and fixation device portfolio with advanced technology is also expected to spur the segmental market. For instance, in August 2020, Innovasis receives first special 510(k) clearance for porous spinal interbody device with HAnano Surface. The newly approved Innovasis micro porous 3D printed titanium devices include the AxTiHA(TM) System, a standalone IBF device for Anterior Lumbar Interbody Fusion (ALIF).
North America is expected to dominate the overall Spinal Implants Market:
North America is expected to dominate the overall Spinal Implants market during the forecast period. This domination is due to the existence of well-established reimbursement scenario for spinal surgeries in the region. In addition, presence of proper and advanced healthcare facilities, and rising prevalence of low back pain in the region is also a factor driving the market in the region.
Further, In the United States, the rising spinal cord injury is also expected to propel the spinal implants market. According to the National SCI Statistical Center 2018, people in the United States the annual incidence of spinal cord injury (SCI) is approximately 54 cases per one million or about 17,700 new SCI cases each year.
In addition, rising spinal surgery volume is also a factor that is anticipated to augment the spinal implant devices in the region. According to a study: Predicting Trends in Cervical Spinal Surgery in the United States from 2020 to 2040 by Neifert S.N. et al., published in NCBI in the year 2020, it was expected that there would be an increase of 13.3% and 19.3% for anterior cervical discectomy and fusion (ACDF) and posterior cervical decompression and fusion (PCDF) from the year 2020-2040.
Moreover, product approvals in the region will also contribute to the spinal implants market in the region. For instance, in August 2020, Orion Biotech Inc. received the US Food & Drug Administration (FDA) approval for Thoracolumbosacral Pedicle Screw System intended to provide posterior, non-cervical immobilization and stabilization of spinal segments in skeletally mature patients.
Further, the Asia-Pacific region has the future potential growth for the Global Spinal Implants. This is due to the increasing per capita healthcare expenditure, improving healthcare infrastructure, rising disposable income, high burden of spine fractures in the region is projected to augment the spinal market in the region. For instance, according to a study: The Burden of Spine Fractures in India by Aleem S.I. et al., in NCBI in the year 2017, most middle aged patients experienced fracture in the lumbar spine region (51%) followed by thoracic (30.7%) and cervical (18.2%).
Spinal Implants Market Key Players:
Some of the key market players operating in the Spinal Fusion Devices market includes Medtronic, Johnson & Johnson, Zimmer Biomet, Stryker Corporation, B. Braun Melsungen AG, NuVasive®, Inc., Orthofix Medical Inc., XTANT MEDICAL, RTI Surgical, Life Spine, Inc., Globus Medical, Captiva Spine, Inc., Medacta International, ATEC Spine, Inc, Advin Health Care, Auxein Medical, Aurora Spine, Spineology Inc., Camber Spine Technologies, LLC, Exactech, Inc., and others.
Recent Developmental Activities in the Spinal Implants Market:
In August 2022, Aurora Spine Corporation received FDA 510(k) clearance for DEXA-C(TM) Cervical Interbody System.
In August 2022, Camber Spine received FDA 510(k) clearance for both its SPIRA-P Posterior Lumbar Spacer technology and SPIRA-T Oblique Posterior Lumbar Spacer technologies.
In March 2022, Aurora Spine Corporation successfully launched its Proprietary SiLO(TM) Posterior SI Joint Fusion System.
In October 2020, Medtronic launched Adaptix Interbody System, a navigated titanium implant with Titan nanoLOCK surface technology, a blend of surface textures on the macro, micro, and nano levels.
Key Takeaways from the Spinal Implants Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Spinal Implants market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Spinal Implants Market.
Various opportunities available for the other competitor in the Spinal Implants Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Spinal Implants market growth in the coming future?
Target Audience who can be benefited from Spinal Implants Market Report Study
Spinal Implants providers
Research organizations and consulting companies
Spinal Implants-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Spinal Implants
Various End-users who want to know more about the Spinal Implants Market and the latest technological developments in the Spinal Implants market.
Frequently Asked Questions for Spinal Implants Market:
Spinal implants are devices surgeons use during surgery to treat deformity, stabilize and strengthen the spine, and facilitate fusion. Disorders treated using spinal implants include degenerative disc disease, scoliosis, kyphosis, spondylolisthesis, and fracture
Global Spinal Implants Market was valued at USD 13.01 billion in 2023, growing at a CAGR of 5.40% during the forecast period from 2024 to 2030 to reach USD 17.84 billion by 2030.
The major factors driving the demand for Spinal Implants are the growing geriatric population coupled with the rising spine deformities, increased preferences for minimally invasive surgeries, technological advancement, among others.
Some of the key market players operating in the Spinal Fusion Devices market includes Medtronic, Johnson & Johnson Services, Inc., Zimmer Biomet, Stryker Corporation, B. Braun Melsungen AG, NuVasive®, Inc., Orthofix Medical Inc., XTANT MEDICAL, RTI Surgical, Life Spine, Inc., Globus Medical, Captiva Spine, Inc., Medacta International, ATEC Spine, Inc, Advin Health Care, Auxein Medical, Aurora Spine, Spineology Inc., Camber Spine Technologies, LLC, Exactech, Inc., and others.
North America is expected to dominate the overall Spinal Implants market during the forecast period 2024-2030. This domination is due to the existence of well-established reimbursement scenario for spinal surgeries in the region. In addition, presence of proper and advanced healthcare facilities, and rising prevalence of low back pain in the region is also a factor driving the market in the region.